We would like to alert the medical community to possible respiratory side effects of vagal nerve stimulation (VNS) during the treatment of nonsurgical refractory partial epilepsy. We observed hypopneic-polypneic episodes during sleep in a 9-year-old girl with epilepsy with continuous spike-waves during slow sleep (CSWSS) syndrome. These events were time-locked to each period of VNS stimulation and occurred without any modification of cardiac frequency. VNS may elicit a reduction of 25-50% in seizure frequency in both adults and children with intractable epilepsy (1). Adverse side effects and complications of VNS were few and mostly transient and were reported in adult patients only. They include hoarseness, neck pain, hypersalivation, cough, and shortness of breath ("air-missing") sensations during physical exercise. These sensations might be related to the increase in end-expiratory volume observed in some patients receiving stimulation at high intensity. In contrast to the common observation that VNS modifies the respiratory pattern in animals, only one study has reported alterations in the respiratory pattern in humans (2).
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In the present case, the mother's pregnancy was marked by fetal death of a twin sister at 24 weeks of postconceptional age. Birth was uneventful at 36 weeks of gestational age. Systematic transfontanellar ultrasound analysis revealed bilateral diffuse periventricular leukomalacia. At age 2 years, she had right tonic partial seizures with loss of contact, and magnetic resonance imaging (MRI) evidenced a left parietal extended ischemic lesion.
At age 5 years, her seizures changed and increased in frequency: during daytime, they were characterized by absence seizures associated with mild and inconstant atonia (up to one seizure every 2-3 min). Sleep EEG showed CSWSS. Over the course of the following year, she was treated unsuccessfully with seven different antiepileptic drugs (AEDs). A ketogenic diet also was ineffective. She was considered an ineligible candidate for surgery because of the extent of the left sylvian ischemic lesion.
At age 6 years, a neurocybernetic prosthesis (Cyberonics, Houston, Texas U.S.A.) was implanted. The stimulation allowed a drug-free period of 2 months, during which there was an initial seizure-free period of 6 weeks. Then absences reappeared but were less numerous than before implantation. Subsequently she was given lamotrigine (LTG) with VNS. Despite the use of various AED combinations and changes in stimulation parameters over the next year, the absences persisted.
At age 6 1 ⁄2 years, while she was being treated with clonazepam (CZP) with VNS, a brief switching off of the stimulator resulted in the frequency of absence returning to preimplantation values (>100/day), indicating the relative efficacy of VNS in CSWSS.
At age 7 years, the introduction of felbamate (FBM) and clobazam (CLB) with high-intensity VNS (intensity, 1.75 mA; frequency, 30 Hz; pulse width, 500 s; and on-time/off-time 60 s/1.8 min) freed the child from seizures for 2 years until the present day.
At age 8 years, an overnight polysomnographic recording included 20 EEG derivations, an electrooculogram, a submental electromyogram, a respiratory piezoelectric device encircling the ribcage, a nasal thermistance, and an electrocardiogram. The VNS signal was monitored by means of two electromyographic surface electrodes placed over the position of the vagal electrodes used for stimulation. The nasal thermistance moved during the recording and did not give reliable values over the whole recording period. Nevertheless, when both traces were recorded, the signal from the piezoelectric device was superimposable on that of the nasal thermistance, which indicated accurate ventilatory monitoring.
The following reproducible markers were used in the data analysis: beginning of inspiration, peak inspiratory velocity (PIV), and peak expiratory velocity (PEV). From pilot evaluations, PIV and PEV did indeed reflect inspiratory and expiratory peak flows. The following time intervals were measured by using these markers: T1, interval between the beginning of inspiration and PIV; T2, interval between the PIV and PEV; and T3, interval between PEV and the beginning of inspiration. Instantaneous respiratory frequency was taken as (T1 + T2 + T3)/60.
Breath-by-breath analysis was performed by using percentage changes, relative to control values, averaged from the three respiratory cycles immediately preceding the onset of the stimulus. Mean changes in ventilatory parameters were assessed by using values calculated within 10-s intervals. Eighty periods of VNS stimulation were examined for this purpose during sleep periods, free of body movement. Differences between control and stimulation periods were tested by using analysis of variance, followed by post hoc PLSD (Protected Least Square Differences) Fisher corrections (StatView+ package).
Every period of VNS was tightly linked to a period of respiratory disturbance, which lasted for the entire period of stimulation. These respiratory modifications were characterized by an immediate decrease in the amplitude of both inspiratory and expiratory movements, as estimated from the piezoelectric trace and also as observed on nasal thermistance. At the same time, respiratory frequency increased (+16.0 ± 2.9%; p < 0.001) secondary to decreases in all the intermediate times (T1, -18.1 ± 3.7%; p < 0.003; T2, -14.8 ± 2.1%; p < 0.0001; T3, -20.4 ± 3%; p < 0.007). This early period lasted for ∼10 s.
After this, the amplitude of respiration progressively returned to control values over the next 50 s. Nevertheless, respiratory frequency remained at a steady, increased value. It was only after a few seconds at the end of VNS stimulation that respiratory frequency and amplitude returned to prestimulation values.
It should be noted that respiratory disturbances were observed throughout the sleep period, but were less easily distinguishable during wakefulness because of incessant movement of the child. In this child, the occurrence of CSWSS prevented any distinction between sleep stages within the EEG recordings, because interictal activity was not sufficiently suppressed to ascertain whether the child was in a rapid eye movement (REM) or non-REM (NREM) sleep period. No change was noticed in cardiac frequency (obtained from the RR interval), global EEG activity, or interspike interval that might be related to individual periods of VNS.
Before implantation of the stimulator, daytime EEG presented a stereotypic pattern of paroxysmal activities. It consisted of a short run of theta waves intermingled with spikes over a 1-s period, followed by a period of 2-3 s relatively free of abnormalities. Then polyspikes occurred for 1 s, rapidly followed by spike-waves at 3 Hz. Spike-waves at a more variable frequency persisted for ∼2 s to several minutes, associated with a loss of contact. After implantation of VNS, in the different periods free from seizures, the stereotypic paroxysmal activities during daytime EEG were modified, being less numerous and more or less confined to the left hemisphere. The sequence of theta run followed by a period free of abnormalities persisted, but polyspikes or synchronized spike-waves at 3 Hz were no longer triggered. Instead, a period of spike-waves at very varied frequencies occurred for short periods, never exceeding 15 s.
Our experience underscores the dual influence of VNS in a case of CSWSS syndrome. This is the first report of respiratory disorders tightly linked to VNS in a child with epilepsy. The changes in both respiratory timing and amplitude were very similar to those previously described in animals in response to electrical stimulation of small myelinated and unmyelinated vagal afferents (3) . As these responses were elicited from the central cut end of the vagus nerve, they were assumed to result from direct interactions with respiratory control centers. They were marked by an earlier onset of both inspiration and expiration, resulting in shortening of both inspiratory and expiratory times, as we also observed. Moreover, the increase in respiratory frequency was associated with a reduction in the amplitude of the pneumogram, an alteration that appeared to be quite similar to that we observed at the beginning of VNS. Animal studies also raised the possibility that the reductions in respiratory flow and the velocity of thoracoabdominal distention might be due to a reflex restrictive respiratory episode. Indeed, the stimulation of the central end of vagus nerve increased the tonic inspiratory activity of the diaphragm, the intercostal, and the laryngeal muscles, which could result in stiffening the respiratory tract and the chest. Finally, the possibility of a direct activation of vagal efferents should not be definitely ruled out in the present case.
Conversely, the present preliminary observation high-lights the potential benefit of VNS in cases of epilepsy with CSWSS. Both the reduction in seizure frequency and the changes in EEG activities indicated that VNS improved the clinical status of the girl under study. As an additional argument, her symptoms immediately worsened during a temporary arrest of the stimulator. Nevertheless, it remains to be determined whether the improvements may be ascribed to VNS itself or to the combination of VNS and FBM. This deserves largerscale evaluations to confirm the therapeutic efficacy of VNS in CSWSS syndrome. In addition, this case report appears sufficiently demonstrative to propose a systematic monitoring of respiratory parameters during overnight polygraphic recordings in patients treated with VNS. This should allow a detailed assessment of the risks of ventilatory disturbances, and their extent, within the range of the clinical applications of VNS.
Extrapolating previous animal data to the present and other findings in humans raises the question whether the occurrence of discrete alterations of ventilatory parameters during VNS might provide a functional indicator of the activation of small myelinated and/or unmyelinated vagal fibers, which has been regarded as a contributing factor to the improvement of epileptic disorders.
Panayiotopoulos Syndrome or Early-onset Benign Childhood Occipital Epilepsy
To the Editor:
The recent "proposed diagnostic scheme for people with epileptic seizures and with epilepsy of the International League Against Epilepsy (ILAE) Task Force on classification" (1) makes a significant contribution by recognizing Panayiotopoulos syndrome (PS) (2) among the idiopathic focal epilepsies of childhood in addition to the "benign childhood epilepsy with centrotemporal spikes" and the "late-onset childhood occipital epilepsy (Gastaut type)." They proposed a descriptive name "early-onset benign childhood occipital epilepsy" attached to an eponym "Panayiotopoulos type (syndrome)" (1) .
I wish to draw attention that the descriptive nomenclature of PS as "occipital epilepsy," also previously described as "with occipital paroxysms," may be misleading.
1. Occipital paroxysms in their classic form with fixation-off sensitivity is a rare finding in PS and certainly nonspecific (3). Interictal EEG in PS mainly manifests with multifocal spikes at various locations, although occipital spikes often (70%) predominate (2, 4, 5) . EEGs may be normal or without occipital spikes (30%) (2, 4, 5) . In the original study of Panayiotopoulos (4) of 21 otherwise normal children with ictal vomiting; occipital spikes occurred in 12 (57%); the others had extraoccipital spikes (five), infrequent brief generalized discharges (one), or consistently normal EEG (three) (4). Subsequent attention was focused on the predominant group of occipital spikes and occipital paroxysms, but this is now corrected to include the group of "extraoccipital spikes or normal EEG."
The clinical manifestations of PS are the same irrespective of EEG localizations. 2. Occipital epilepsy also is incorrect for the following good reasons: (a) onset of seizures is mainly with autonomic symptoms and particularly emesis (80%) (5). Of occipital symptoms, only deviation of the eyes may originate from the occipital regions, but this rarely occurs at onset. Visual symptoms are exceptional and not consistent in recurrent seizures; (b) interictal occipital spikes may never occur, (c) even ictal EEG has documented anterior onset (6). 3. Characterizing PS as "epilepsy" also is controversial and, in my opinion, unsatisfactory. One third of children with PS have a single seizure, which by the operational definition of epilepsy (more than two seizures) is not epilepsy. Further, PS is not "a chronic neurological condition characterized by recurrent epileptic seizures" (the current definition of the ILAE glossary) (7).
All these point out that PS should be classified among "conditions with epileptic seizures that do not require a diagnosis of epilepsy," which is a new concept of the ILAE proposal to incorporate febrile, benign neonatal, single seizures, isolated clusters of seizures, and rarely repeated seizures (oligoepilepsy) (1). PS is a common clinical phenotype of the benign childhood seizure susceptibility syndrome (2, 5) . It manifests with autonomic seizures and autonomic status epilepticus that in one third are singular events. Prognosis is excellent even for those (∼10%) who may initially have many seizures. Interictal EEG shows significant variability, even for the same child. Predominantly PS affects children aged 3-7 years, probably as the result of susceptible emetic and autonomic centers of this age group (5 The number of seizures before the start of treatment has been found in some but not all studies to be a risk factor for intractability. In any case, we concur with Dr. Reynolds in that it appears to be a relevant risk factor. In a recent article from one of us (1), it was confirmed that those patients with 20 or more seizures before treatment had a significantly higher chance of intractability.
Finally, in our text, we discussed the phenomenon of secondary epileptogenesis and of the possibility that seizures beget seizures. Unfortunately, because of numerous methodologic issues, the evidence that this phenomenon occurs in humans has been difficult to ascertain. In this sense, different types of epilepsy might behave differently. Even in those types that we believe are progressive (like mesial temporal lobe epilepsy), an initial and sometimes years-long "honeymoon period" is often observed, implying that the disease evolution and not the seizures in themselves might be responsible for the intractability. 
